ALK-Abelló A/S (CPH:ALK.B)
Denmark · Delayed Price · Currency is DKK 218.20
-6.20 (-2.76%)
At close: Dec 16, 2025
ALK-Abelló Market Cap
ALK-Abelló has a market cap or net worth of 48.26 billion as of December 17, 2025. Its market cap has increased by 37.49% in one year.
Market Cap
48.26B
Enterprise Value
48.06B
Revenue
6.08B
Ranking
n/a
PE Ratio
43.86
Stock Price
218.20
Market Cap Chart
Since December 27, 2005, ALK-Abelló's market cap has increased from 6.91B to 48.26B, an increase of 598.66%. That is a compound annual growth rate of 10.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 48.26B | 37.15% |
| Dec 30, 2024 | 35.19B | 57.21% |
| Dec 29, 2023 | 22.38B | 5.48% |
| Dec 30, 2022 | 21.22B | -43.63% |
| Dec 30, 2021 | 37.65B | 37.96% |
| Dec 30, 2020 | 27.29B | 53.31% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.43T |
| Coloplast | 127.11B |
| Genmab | 124.12B |
| Demant | 46.39B |
| H. Lundbeck | 41.34B |
| Zealand Pharma | 34.64B |
| Ambu A/S | 23.15B |
| GN Store Nord | 16.46B |